In response to a recent comment, I took a new look at the database of clinical trials that are recruiting subjects for oxytocin studies, available at ClinicalTrials.gov. I see that Daniel Feifel of the University of California San Diego is recruiting subjects for two studies to test oxytocin on symptoms of schizophrenia.
And it looks like Evdokia Anagnostou of Eric Hollander's Mt. Sinai team is recruiting for a couple of studies of adults with ASD, although it's hard to tell if the database is current.
Meanwhile, the National Institutes of Mental Health is recruiting for a study of people without psychiatric diagnoses on "Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders."
We can expect more and more of these as #1 scientists strive to learn more and more about the neurochemical basis of emotion and #2 pharm companies look for new classes of drugs they can sell.